HOME >> BIOLOGY >> NEWS
$3.2 million project to document dioxin levels in Houston ship channel

HOUSTON, Nov. 12, 2002 A major scientific study under way in Texas may help clarify how toxic chemicals are transported through the environment.

Since last summer, University of Houston environmental engineers have been taking hundreds of water, fish and sediment samples from the Houston Ship Channel to determine what levels of dioxins, if any, are present. The researchers will use that data, and more gathered through spring 2003, to develop new computer models to find out where such contaminants originate and to track how they move through the environment, possibly ending up in crab and fish that travel to fishing regions.

"This aspect of the study is quite interesting because such a comprehensive model has never been attempted before," says Hanadi Rifai, associate professor of environmental engineering at UH and principal investigator on the Ship Channel project. "I think this project will set the trend for a lot of national studies looking at these compounds and we'll have many people looking at our results." In the spring of 2002, Rifai received a $3.2 million grant from the Texas Natural Resource and Conservation Commission (now called the Texas Commission on Environmental Quality) to fund her project in the Houston Ship Channel, home to one of the world's largest industrial complexes. Results from the study will be used by regulatory agencies to help craft implementation plans for reducing pollutants and achieving minimum water quality standards.

The Environmental Protection Agency currently is preparing a comprehensive reassessment of the scientific consensus on dioxin, including its sources, its fate and transport, levels of human exposure, and its toxic effects on humans and other animals. EPA information on dioxins is available on the Web at http://cfpub.epa.gov/ncea/cfm/dioxin.cfm

"Dioxins are a family of contaminants that are very tough to understand in terms of
'"/>

Contact: Amanda Siegfried
asiegfried@uh.edu
713-743-8192
University of Houston
12-Nov-2002


Page: 1 2 3 4

Related biology news :

1. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
2. Half-million dollar landmark achieved for the Methuselah Mouse Prize
3. HHMI, NIBIB/NIH to invest up to $35 million in interdisciplinary Ph.D. programs
4. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
5. $2.7 million grant to support creation of virtual zebrafish atlas
6. Tufts University establishes $4 million dollar tissue engineering resource center
7. PNNL lands $10.3 million NIH biodefense contract to unlock proteomes of salmonella and pox
8. $18 million bioinformatics center to become weapon against deadly diseases
9. Pacific Northwest National Laboratory gets $10 million from NIH to build virtual lung
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. UCR earns $1.5 million grant to examine how engineered crop genes stray

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: million project document dioxin levels Houston ship channel

(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a developer ... helmet producer, announced today that they will expand their ... world,s first bio-sensing cycling helmet and the first joint ... two new colors in order to give cyclists more ... In addition, LifeBEAM and Lazer announced their plan to ...
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/20/2015)... 20, 2015 Huntington Memorial Hospital is the ... a new miniaturized, wireless monitoring sensor to manage heart ... and only FDA-approved heart failure monitoring device that has ... by physicians to manage heart failure. The ... in the pulmonary artery (PA) during a non-surgical procedure ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
(Date:5/22/2015)... 2015  Actavis plc (NYSE: ACT ) today ... Appeals for the Second Circuit has issued a ruling ... Company to continue distribution of NAMENDA ® (memantine ...   "While we are disappointed by ... to continue our strong efforts to convey the significant ...
(Date:5/21/2015)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... and commercializes proprietary technologies and products for advanced microarray ... the second fiscal quarter ended March 31, 2015. ... advance business with our existing customers and to develop ... CEO of SQI. "The delivery of a fully automated ...
(Date:5/21/2015)... 2015 uBiome, the leading startup ... with PicnicHealth, a healthcare company that collects and ... Inflammatory Bowel Disease (IBD) will receive a complementary ... research kit. Both companies were funded by Y ... For more information on this partnership and how ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
Breaking Biology Technology:Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
Cached News: